首页> 外国专利> COMPOSITION HAVING BOTH DIPEPTIDYL PEPTIDASE IV INHIBITORY ACTIVITY IN BLOOD AND SECRETION PROMOTION ACTIVITY OF GLUCAGON-LIKE PEPTIDE-1

COMPOSITION HAVING BOTH DIPEPTIDYL PEPTIDASE IV INHIBITORY ACTIVITY IN BLOOD AND SECRETION PROMOTION ACTIVITY OF GLUCAGON-LIKE PEPTIDE-1

机译:具有二肽肽酶IV的组合物在葡萄糖中的抑制活性和类葡聚糖肽-1的分泌促进活性

摘要

PROBLEM TO BE SOLVED: To provide a material effective for preventing and treating diabetes and obesity by increasing endogenous GLP-1.;SOLUTION: Glucagon-like peptide-1 (GLP-1) being a digestive tract hormone is known to have an antidiabetic effect, however, only promotion of secretion of GLP-1 exhibits an insufficient effect, inhibition of decomposition as well as promotion of secretion is effective, concretely, a remarkable effect is obtained by inhibiting dipeptidyl peptidase-IV(DPP-IV) in blood. The preventive or therapeutic agent for diabetes or obesity comprises corn protein Zein hydrolyzate (ZeinH) having both secretion promotion action on GLP-1 and inhibitory action on DPP-IV or its amino acid sequence Leu-Pro-Phe as an active ingredient.;COPYRIGHT: (C)2011,JPO&INPIT
机译:解决的问题:提供一种通过增加内源性GLP-1来有效预防和治疗糖尿病和肥胖症的材料。解决方案:已知胰高血糖素样肽1(GLP-1)是消化道激素,具有抗糖尿病作用然而,仅促进GLP-1的分泌表现出不足的作用,抑制分解以及促进分泌是有效的,具体而言,通过抑制血液中的二肽基肽酶-IV(DPP-IV)获得了显着的效果。糖尿病或肥胖症的预防或治疗剂包括玉米蛋白玉米蛋白水解蛋白(ZeinH),其既对GLP-1具有促分泌作用,又对DPP-IV或其氨基酸序列Leu-Pro-Phe的氨基酸活性具有抑制作用。 :(C)2011,JPO&INPIT

著录项

  • 公开/公告号JP2011182742A

    专利类型

  • 公开/公告日2011-09-22

    原文格式PDF

  • 申请/专利权人 HARA HIROSHI;HIRA TORU;ASANO KOZO;

    申请/专利号JP20100053383

  • 发明设计人 HARA HIROSHI;ASANO KOZO;HIRA TORU;

    申请日2010-03-10

  • 分类号A23L1/305;A23L1/30;A61K38/00;A61P43/00;A61P3/04;A61P3/10;C07K5/083;C07K14/425;

  • 国家 JP

  • 入库时间 2022-08-21 18:25:01

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号